Skip to Content Facebook Feature Image

DHL Express launches direct Shanghai-Bangkok flight to support growing trade flows across China and Indochina

Asia Pacific

DHL Express launches direct Shanghai-Bangkok flight to support growing trade flows across China and Indochina
Asia Pacific

Asia Pacific

DHL Express launches direct Shanghai-Bangkok flight to support growing trade flows across China and Indochina

2026-08-11 12:20 Last Updated At:12:22

New DHL daily flight service on Boeing 767 freighter strengthens connections between China, Indochina, the Middle East and Europe

SINGAPORE – Media OutReach Newswire – 11 August 2026 – DHL Express has added a new direct flight between Shanghai and Bangkok, increasing capacity on a trade lane linking China and the rapidly growing economies of Indochina. The new flight route, Shanghai-Bangkok-Bahrain*-Brussels-Shanghai, significantly enhances connectivity among manufacturing, sourcing, and consumption markets across Asia, the Middle East, and Europe.

DHL Express boosts Indochina connectivity with new Shanghai-Bangkok flight

DHL Express boosts Indochina connectivity with new Shanghai-Bangkok flight

Operated by a DHL Boeing 767 freighter with a maximum payload of 50 tons, the new daily service demonstrates DHL Express's ongoing investments in network capacity and infrastructure to strengthen connectivity for customers in high-growth markets. Equally, it also reflects DHL's constant review of evolving trade patterns and swift action to adapt to those changes.

"This route is a direct response to how trade flows in Asia are shifting," said Peter Bardens, Senior Vice President for Network Operations & Aviation – Asia Pacific, DHL Express. "We're seeing increasing movement of goods between China and Southeast Asia, alongside continued demand from customers in Europe and the Middle East for products manufactured across the region. This new route boosts our network where customers need it most, providing additional capacity and more direct connections between key production and consumption markets."

Bangkok serves as a strategic gateway to the Indochina region, while Bahrain and Brussels are key DHL Express hubs. The introduction of the Shanghai-Bangkok route enables DHL Express to efficiently consolidate shipments originating from China and Southeast Asia before connecting them to destinations across Europe and the Middle East.

The direct flight comes at a time when manufacturers and traders in markets such as Thailand, Vietnam, Cambodia and Laos are sourcing more from China. For many customers, those shipments are part of production chains that stretch across multiple countries. As trade links between China and Southeast Asia deepen, DHL Express is improving speed, flexibility and network resilience for customers moving materials, components and finished products across Asia and onward to global markets. Last month, DHL Express also expanded its Shenzhen gateway, located at Shenzhen Bao'an International Airport. The facility can handle 900 tons of cargo daily – approximately three times the original throughput – as it supports booming cross-border trade and e-commerce shipments in China.

At the same time, businesses in Europe and the Middle East continue to trade heavily with their peers in China and Southeast Asia for a wide range of products, from electronics and industrial components to consumer goods. As international business activity remains highly dispersed across global markets rather than concentrating within regions, the new route opens more trading opportunities for businesses while strengthening access for both regions.

As both intra-Asia and global trade flows continue to show resilience, DHL remains focused on investing in its dedicated air network. Another recent example includes the introduction of a new transpacific service by DHL Global Forwarding that connects Southeast Asia and the United States. These expansions seek to better connect businesses to global markets as well as build more agile supply chains.

*Note to editor: Due to the current conflict in Middle East, flights are tentatively diverted to other locations in the Middle East.
Hashtag: #DHLExpress #Globaltrade #Indochina


The issuer is solely responsible for the content of this announcement.

DHL – The logistics company for the world

DHL is the leading global brand in the logistics industry. Our DHL divisions offer an unrivaled portfolio of logistics services ranging from national and international parcel delivery, e-commerce shipping and fulfillment solutions, international express, road, air and ocean transport to industrial supply chain management. With approximately 389,000 employees in more than 220 countries and territories worldwide, DHL connects people and businesses securely and reliably, enabling global sustainable trade flows. With specialized solutions for growth markets and industries including technology, life sciences and healthcare, engineering, manufacturing & energy, auto-mobility and retail, DHL is decisively positioned as "The logistics company for the world".

DHL is part of DHL Group. The Group generated revenues of approximately 82.9 billion euros in 2025. With sustainable business practices and a commitment to society and the environment, the Group makes a positive contribution to the world. DHL Group aims to achieve net-zero emissions logistics by 2050.

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **

  • Expansion adds first BioReliance® Cell Line Characterization and GMP Next-GenerationSequencingin Asia Pacific
  • Enhanced testing capabilities to deliver speed, sensitivity, and sustainability for biopharma customers in the region
  • Supports industry shift to molecular methods and animal-free testing

SINGAPORE – Media OutReach Newswire – 11 August 2026 – Merck, a leading science and technology company, is expanding its Singapore lab to further strengthen analytical and biosafety testing services for customers across the Asia Pacific region. Biosafety testing is a critical step in the drug development and manufacturing process, helping to ensure that biologics are safe, effective, and compliant with regulatory requirements.

The expansion builds on Merck's global testing expertise of more than 75 years and marks a significant milestone in providing an advanced, local contract testing services portfolio for the region's growing biopharma industry.

"Localizing these BioReliance® testing capabilities means our Asia Pacific biopharma customers can accelerate their development timelines, improve operational efficiency, and meet evolving regulatory and sustainability standards" said Paolo Carli, Head of Advanced Solutions for the Life Science business of Merck. "This investment underscores Merck's commitment to empowering medicine makers by providing industry-leading analytical and biosafety testing services and technical expertise."

Merck's Singapore laboratory will become the first BioReliance® facility in Asia-Pacific to offer both Cell Line Characterization services and GMP next-generation sequencing (NGS) capabilities. It will also offer advanced molecular methods including Blazar®, a proprietary platform for rapid virus detection.

The expanded facility aims to support the industry's move towards state-of-the-art quality control testing of biologics and 3Rs (Replacement, Reduction, and Refinement of animal use) through advanced molecular methods.

"Merck's expansion of the BioReliance® lab will bring world-class and next-generation testing services to biopharmaceutical companies in Singapore and the region. We look forward to continuing our partnership with Merck to strengthen Singapore's ecosystem, build new capabilities within our local workforce, and enable the delivery of innovative therapies to patients," said Goh Wan Yee, Senior Vice President and Head of Healthcare, Singapore Economic Development Board.

The Singapore BioReliance® lab was opened in 2018, and the expansion will bring the total lab area to over 1,000 square meters. This expansion is also a key step in Merck's broader strategy to support the region's dynamic life science ecosystem and drive scientific progress.

Hashtag: #Merck #BioReliance #biosafety

The issuer is solely responsible for the content of this announcement.

About Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 62,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2025, Merck generated sales of € 21.1 billion in 65 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to to register online, change your selection or discontinue this service.

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **

Recommended Articles